MicroRNA-29-3p Regulates Hepatocellular Carcinoma Progression Through NF-κB Pathway

Clin Lab. 2019 May 1;65(5). doi: 10.7754/Clin.Lab.2018.181012.

Abstract

Background: Hepatocellular carcinoma (HCC) is the most common primary liver cancer and accounts for over 90% of all primary liver cancers. Increasing evidence suggests that microRNAs (miRNAs) mediate signaling pathways by gene expression regulation.

Methods: In this study, we evaluated the role of miR-29a-3p in HCC progression. MiR-29a-3p was found significantly down-regulated in HCC tissues compared to adjacent non-tumor tissues. Meantime, PTEN expression was up-regulated in HCC tissues. Moreover, NF-κB activity was decreased following PTEN up-regulation.

Results: In vitro assays in the HCC cell line BEL7402 demonstrated that miR-29a-3p suppresses cell proliferation.

Conclusions: miR-29a-3p participates in the HCC progression by regulation of NF-κB pathway via targeting PTEN.

MeSH terms

  • Alcoholism / complications
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / metabolism
  • Cell Line, Tumor
  • Disease Progression
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Liver Neoplasms / complications
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / metabolism
  • MicroRNAs / genetics*
  • NF-kappa B / metabolism*
  • PTEN Phosphohydrolase / genetics
  • PTEN Phosphohydrolase / metabolism
  • Signal Transduction

Substances

  • MIRN29a microRNA, human
  • MicroRNAs
  • NF-kappa B
  • PTEN Phosphohydrolase
  • PTEN protein, human